Physician profile
Larry Salberg
NPI 1073666749
$26,596.92
in general payments reported to CMS, 2019-2025
81 companies · $4,765 in 2025
The $4,765 reported for 2025 was more than what 85% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,958 · 2020: $2,697 · 2021: $3,779 · 2022: $4,092 · 2023: $4,291 · 2024: $5,015 · 2025: $4,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,940.21 |
| Education | $130.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,390.43 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Jazz Pharmaceuticals INC. | $1,905.32 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,813.81 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $1,576.40 | 2019-2025 | |
| Abbvie INC. | $1,352.92 | 2021-2025 | Botox, Vraylar, Qulipta |
| Neurocrine Biosciences, INC. | $1,031.38 | 2019-2025 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $768.43 | 2019-2024 | Ultomiris, Soliris |
| Avadel Cns Pharmaceuticals, LLC | $682.01 | 2024-2025 | Lumryz |
| Lundbeck LLC | $671.25 | 2020-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $632.88 | 2019-2025 | Nuplazid, Daybue |
| Acorda Therapeutics, INC | $609.11 | 2019-2024 | Inbrija, Ampyra |
| Axsome Therapeutics, INC. | $596.94 | 2022-2025 | Sunosi, Auvelity, Symbravo |
| Lilly USA, LLC | $590.54 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Celgene Corporation | $585.27 | 2021-2025 | Zeposia |
| Allergan, INC. | $553.06 | 2019-2022 |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $501.51 | 2022-2025 | Inspire |
| Amgen INC. | $483.41 | 2019-2025 | Uplizna, Aimovig |
| Ucb, INC. | $478.60 | 2019-2025 | Briviact, Nayzilam |
| Sk Life Science, INC. | $468.02 | 2021-2025 | Xcopri |
| Eisai INC. | $430.08 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $411.04 | 2019-2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $408.38 | 2021-2022 | |
| Emd Serono, INC. | $367.72 | 2019-2025 | Mavenclad |
| Harmony Biosciences LLC | $367.06 | 2020-2025 | Wakix |
| Catalyst Pharmaceuticals, INC. | $366.63 | 2020-2025 | Fycompa |
| Argenx US, INC. | $363.13 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Pfizer INC. | $355.80 | 2019-2025 | |
| Neurelis, INC. | $344.23 | 2022-2025 | Valtoco |
| Livanova USA, INC. | $339.26 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Supernus Pharmaceuticals, INC. | $313.61 | 2019-2024 | Qelbree |
| Corium, LLC | $311.79 | 2022-2024 | Azstarys, Adlarity |
| Mdd US Operations, LLC | $272.84 | 2019-2025 | Apokyn, Apokyn |
| Merz Pharmaceuticals, LLC | $271.72 | 2022-2025 | Xeomin, Ampyra, Inbrija |
| Otsuka America Pharmaceutical, INC. | $268.32 | 2020-2023 | Rexulti, Nuedexta |
| Genentech USA, INC. | $255.79 | 2020-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Tg Therapeutics, INC. | $252.04 | 2023-2025 | |
| Sunovion Pharmaceuticals INC. | $243.89 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $205.67 | 2019-2021 | |
| Kyowa Kirin, INC. | $193.33 | 2020-2024 | Nourianz |
| Genzyme Corporation | $164.18 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $139.34 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $131.12 | 2022 | |
| Ironshore Pharmaceuticals INC. | $130.87 | 2020-2024 | Jornay Pm |
| Banner Life Sciences, LLC | $129.66 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $118.37 | 2024-2025 | Ponvory, Fanapt |
| Tanabe Pharma America, INC. | $118.23 | 2021-2025 | Radicava |
| Octapharma USA, INC. | $110.70 | 2024-2025 | Panzyga |
| Upsher-Smith Laboratories LLC | $101.15 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $94.12 | 2023 | Aptiom |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $84.24 | 2025 | Caplyta |
| Bausch Health US, LLC | $82.90 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $74.52 | 2020-2025 | Crexont |
| Ani Pharmaceuticals, INC. | $68.12 | 2022-2025 | Purified Cortrophin Gel |
| Avanir Pharmaceuticals, INC. | $62.36 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $61.66 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $54.53 | 2020-2021 | |
| Abbott Laboratories | $53.65 | 2021-2023 | Infinity |
| Cycle Pharmaceuticals INC | $52.55 | 2025 | Bafiertam, Tascenso Odt |
| Almatica Pharma LLC | $51.62 | 2022-2023 | Gralise |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $50.81 | 2025 | Rexulti |
| Itamar Medical INC | $50.24 | 2024 | Watchpatone |
| Csl Behring | $47.00 | 2020-2022 | |
| Aucta Pharmaceuticals, INC. | $43.74 | 2025 | Motpoly Xr |
| Avion Pharmaceuticals | $43.14 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $41.02 | 2021 | |
| Alfasigma USA, INC. | $40.85 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $37.90 | 2021 | |
| Akcea Therapeutics, INC. | $37.89 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $30.65 | 2020 | |
| Tris Pharma INC | $29.32 | 2024 | Dyanavel Xr |
| Assertio Therapeutics, INC. | $29.15 | 2019 | |
| Impel Pharmaceuticals INC. | $27.53 | 2023 | Trudhesa |
| Mallinckrodt Enterprises LLC | $25.83 | 2019 | |
| Vertical Pharmaceuticals, LLC | $25.58 | 2019-2020 | |
| Janssen Biotech, INC. | $23.57 | 2025 | |
| Azurity Pharmaceuticals, INC. | $22.77 | 2024 | Horizant |
| Boston Scientific Corporation | $19.54 | 2021 | |
| Merck Sharp & Dohme LLC | $16.83 | 2022 | |
| Cala Health, INC. | $14.53 | 2024 | Cala Kiq, Cala Trio |
| Merz North America, INC. | $12.32 | 2020 | |
| Impel Pharmaceuticals LLC | $9.20 | 2024 | Trudhesa |
Drugs and devices associated with these payments
Tysabri $995Vumerity $906Kesimpta $836Xywav $776Lumryz $682Ingrezza $576Austedo Xr $535Qulipta $483Botox $442Sunosi $421Inspire $383Zeposia $383Epidiolex $381Amyvid $348Nurtec Odt $319Fycompa $315Nuplazid $292Zavzpret $291Ubrelvy $276Vyvgart $258Briumvi $252Daybue $251Ultomiris $245Inbrija $231Briviact $216Ampyra $207Rexulti $206Wakix $206Ongentys $194Valtoco $176Kisunla $174Azstarys $169Xeomin $161Vns Therapy Sentiva Model 1000 Generator $160Mayzent $157Bafiertam $137Emgality $134Xcopri $127Vyepti $125Panzyga $121Ocrevus $115Vyvgart Hytrulo $105Ponvory $104Xyrem $99.99Aptiom $94.12Ocrevus Zunovo $89.33Auvelity $88.63Avonex $84.56Caplyta $84.24Leqembi $82.93Austedo $74.61Reyvow $73.06Adlarity $72.99Jornay Pm $72.14Nayzilam $68.06Symbravo $65.87Qelbree $63.66Apokyn $57.83Vraylar $57.07Watchpatone $50.24Skyclarys $49.17Soliris $47.43Purified Cortrophin Gel $43.76Motpoly Xr $43.74Uplizna $43.05Mavenclad $41.68Paxlovid $40.69Comirnaty $38.35Trudhesa $36.73Gralise $36.46Tascenso Odt $34.34Nourianz $33.01Dyanavel Xr $29.32Ztlido $28.39Crexont $28.11Zepbound $23.32Horizant $22.77Radicava $21.09Duopa $18.19Elyxyb - Celecoxib $15.73Infinity $15.56Cala Kiq $14.53Cala Trio $14.53Fanapt $14.40Plegridy $14.36Aimovig $14.13Enspryng $14.08Trintellix $13.87Nuedexta $13.69Octagam Immune Globulin (Human) $10.37Vyalev $4.43
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Salberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.